Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Change in Acquisitions & Divestments (2016 - 2018)

Firefly Neuroscience has reported Change in Acquisitions & Divestments over the past 7 years, most recently at $1719.0 for Q1 2018.

  • Quarterly results put Change in Acquisitions & Divestments at $1719.0 for Q1 2018, up 77.58% from a year ago — trailing twelve months through Dec 2018 was $1719.0 (down 49.6% YoY), and the annual figure for FY2018 was $1719.0, down 49.6%.
  • Change in Acquisitions & Divestments for Q1 2018 was $1719.0 at Firefly Neuroscience, up from $770.0 in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for AIFF hit a ceiling of $1719.0 in Q1 2018 and a floor of $280.0 in Q1 2016.
  • Median Change in Acquisitions & Divestments over the past 4 years was $936.0 (2017), compared with a mean of $854.82.
  • Biggest five-year swings in Change in Acquisitions & Divestments: tumbled 57.32% in 2016 and later soared 245.71% in 2017.
  • Firefly Neuroscience's Change in Acquisitions & Divestments stood at $479.0 in 2015, then soared by 100.21% to $959.0 in 2016, then fell by 19.71% to $770.0 in 2017, then surged by 123.25% to $1719.0 in 2018.
  • The last three reported values for Change in Acquisitions & Divestments were $1719.0 (Q1 2018), $770.0 (Q4 2017), and $737.0 (Q3 2017) per Business Quant data.